Italia markets closed

CSL Ltd (CSJ.DU)

Dusseldorf - Dusseldorf Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
170,50-0,70 (-0,41%)
Alla chiusura: 07:30PM CEST
Schermo intero
Chiusura precedente171,20
Aperto170,00
Denaro170,60 x 0
Domanda173,40 x 0
Min-Max giorno169,90 - 170,50
Intervallo di 52 settimane135,10 - 192,50
Volume15
Media Volume0
CapitalizzazioneN/D
Beta (mensile su 5 anni)N/D
Rapporto PE (ttm)N/D
EPS (ttm)N/D
Prossima data utili13 ago 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    uniQure announces achievement of $100 million milestone related to hemophilia B gene therapy

    Milestone payment triggered by first commercial sale of HEMGENIX® in U.S. by CSL BehringLEXINGTON, Mass. and AMSTERDAM, June 20, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, announced the achievement of a $100 million milestone associated with the first commercial sale of HEMGENIX® in the United States by its partner, global biotechnology leader CSL (ASX: CSL). HEMGENIX® (etranacoge